ESCRS - Macular disease and cataracts: Threshold for surgery should be low ;
ESCRS - Macular disease and cataracts: Threshold for surgery should be low ;

Macular disease and cataracts: Threshold for surgery should be low

Macular disease and cataracts: Threshold for surgery should be low
Dermot McGrath
Dermot McGrath
Published: Monday, September 26, 2016
congress-news_wolf_2096 Cataract surgery in patients with macular disease should be performed if the patient has cataract-related visual symptoms, according to Sebastian Wolf MD, PhD. “The take-home message is that the threshold for cataract surgery should be low and even patients with reduced visual potential may benefit from cataract surgery,” Dr Wolf told delegates attending yesterday’s ESCRS Clinical Research Symposium on cataract and macular disease in Copenhagen. Dr Wolf, of Switzerland, said that the question of whether cataract surgery is safe for someone with age-related macular degeneration (AMD) or other retinal disease is regularly posed by both patients and their treating physicians. While patients often worry that having the surgery will worsen their disease, there is no clear evidence that cataract surgery promotes AMD progression, he said. Dr Wolf said that cataract surgery is indicated when vision loss interferes with everyday activities. “We need to remember that cataract removal is one of the most common, safest and effective operations in medicine. In more than 90% of cases, people who have cataract surgery have better vision afterwards. Cataract surgery does, however, increase the risk of retinal detachment and it is true that the interaction between macular disease and cataract surgery is still very much under discussion,” he said. In terms of diagnostics that best predict the risk-benefit curve in patients with cataract and macular disease, Dr Wolf warned that ophthalmoscopy may be compromised by the presence of cataract. By contrast, optical coherence tomography (OCT) is also particularly useful in such patients, he said. “We typically use OCT, and the big advantage of this is that infrared light can penetrate even dense nuclear cataracts and give us a clearer view of the retina and macula,” he added.    
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;